Literature DB >> 11689516

Persistence of vaccine-derived poliovirus following a mass vaccination campaign in Cuba: implications for stopping polio vaccination after global eradication.

P Más Lago1, V M Cáceres, M A Galindo, H E Gary, M Valcarcel, J Barrios, L Sarmiento, I Avalos, J A Bravo, R Palomera, M Bello, R W Sutter, M A Pallansch, C A de Quadros.   

Abstract

BACKGROUND: With substantial progress made toward polio eradication, developing the appropriate strategy for discontinuing global oral poliovirus vaccine (OPV) after global eradication becomes increasingly important. At issue is the theoretical risk of independent circulation of potentially virulent OPV-derived strains. Because Cuba uses OPV only in mass campaigns, it represents an ideal site to assess vaccine-derived poliovirus persistence.
METHODS: Infants born after the 1997 biannual mass campaigns were evaluated for past (neutralizing antibody) or current (virus excretion) evidence of vaccine-derived poliovirus exposure. We obtained sera and/or stool specimens from 861 infants; a second serum from 218 infants.
RESULTS: All stool specimens were poliovirus negative. Of 762 infants, 113 (14.8%) had initially detectable poliovirus type 1 antibody, 193 (25.3%) type 2, and 94 (12.3%) type 3. A precipitous antibody decline occurred in initially positive sera.
CONCLUSIONS: Our results suggest that in a country with high population immunity, vaccine-derived virus is unlikely to establish ongoing circulation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11689516     DOI: 10.1093/ije/30.5.1029

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  11 in total

1.  Retrospective analysis of a local cessation of vaccination against poliomyelitis: a possible scenario for the future.

Authors:  Ekaterina A Korotkova; Renee Park; Elena A Cherkasova; Galina Y Lipskaya; Konstantin M Chumakov; Esfir V Feldman; Olen M Kew; Vadim I Agol
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

Review 2.  Polio elimination in Nigeria: A review.

Authors:  Usman Nakakana Nasir; Ananda Sankar Bandyopadhyay; Francesca Montagnani; Jacqueline Elaine Akite; Etaluka Blanche Mungu; Ifeanyi Valentine Uche; Ahmed Mohammed Ismaila
Journal:  Hum Vaccin Immunother       Date:  2016-03-03       Impact factor: 3.452

Review 3.  The final stages of the global eradication of poliomyelitis.

Authors:  Nicholas C Grassly
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-06-24       Impact factor: 6.237

Review 4.  From emergence to eradication: the epidemiology of poliomyelitis deconstructed.

Authors:  Neal Nathanson; Olen M Kew
Journal:  Am J Epidemiol       Date:  2010-10-26       Impact factor: 4.897

5.  Rapid Disappearance of Poliovirus Type 2 (PV2) Immunity in Young Children Following Withdrawal of Oral PV2-Containing Vaccine in Vietnam.

Authors:  Dang Thi Thanh Huyen; Ondrej Mach; Nguyen Thanh Trung; Pham Quang Thai; Ho Vinh Thang; William C Weldon; M Steven Oberste; Visalakshi Jeyaseelan; Roland W Sutter; Dang Duc Anh
Journal:  J Infect Dis       Date:  2019-07-02       Impact factor: 7.759

6.  Modeling undetected live poliovirus circulation after apparent interruption of transmission: implications for surveillance and vaccination.

Authors:  Dominika A Kalkowska; Radboud J Duintjer Tebbens; Mark A Pallansch; Stephen L Cochi; Steven G F Wassilak; Kimberly M Thompson
Journal:  BMC Infect Dis       Date:  2015-02-18       Impact factor: 3.090

7.  Lessons From Globally Coordinated Cessation of Serotype 2 Oral Poliovirus Vaccine for the Remaining Serotypes.

Authors:  Kimberly M Thompson; Radboud J Duintjer Tebbens
Journal:  J Infect Dis       Date:  2017-07-01       Impact factor: 5.226

8.  Limited duration of vaccine poliovirus and other enterovirus excretion among human immunodeficiency virus infected children in Kenya.

Authors:  Nino Khetsuriani; Rita Helfand; Mark Pallansch; Olen Kew; Ashley Fowlkes; M Steven Oberste; Peter Tukei; Joseph Muli; Ernest Makokha; Howard Gary
Journal:  BMC Infect Dis       Date:  2009-08-23       Impact factor: 3.090

9.  Poliovirus Type 2 Seroprevalence Following Full- or Fractional-Dose Inactivated Poliovirus Vaccine in the Period After Sabin Type 2 Withdrawal in Sri Lanka.

Authors:  Deepa Gamage; Ondrej Mach; Samitha Ginige; William C Weldon; M Steven Oberste; Visalakshi Jeyaseelan; Roland W Sutter
Journal:  J Infect Dis       Date:  2019-05-24       Impact factor: 7.759

10.  Does Simultaneous Administration of Bivalent (Types 1 and 3) Oral Poliovirus Vaccine and Inactivated Poliovirus Vaccine Induce Mucosal Cross-immunity to Poliovirus Type 2?

Authors:  Sonia Resik; Alina Tejeda; Ondrej Mach; Magile Fonseca; Manuel Diaz; Nilda Alemany; Lai Heng Hung; Yoan Aleman; Ileana Mesa; Gloria Garcia; Roland W Sutter
Journal:  Clin Infect Dis       Date:  2018-10-30       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.